HRR Deficiency
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors (NCT07088588) | Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd | 2025-07-31 |
| Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors (NCT06666270) | Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd | 2024-11-21 |
| EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors (NCT06525298) | Eisbach Bio GmbH | 2024-09-09 |
Track HRR Deficiency automatically
Every clearance here is in the API, with alerts when new ones post.